About this trial
Video-assisted thoracoscopic surgery (VATS) is associated with significant postoperative pain despite lower morbidity compared with thoracotomy. Adequate pain management is essential within Enhanced Recovery After Surgery (ERAS) pathways to preserve respiratory function and facilitate postoperative recovery. Surgical intercostal block performed under direct vision is a simple and effective regional analgesic technique commonly used following VATS. However, the optimal timing of intercostal block administration during surgery remains uncertain.
This prospective randomized double-blind study will compare surgical intercostal block performed at the beginning versus the end of the surgical procedure. The study aims to evaluate the effect of block timing on postoperative pain intensity and postoperative opioid consumption. The results may help optimize multimodal analgesic strategies in patients undergoing thoracic surgery.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Scheduled for single-port or two-port video-assisted thoracoscopic surgery (VATS).
ASA classification 1 to 3
Able to understand the study, describe their pain and provide valid informed consent
Disqualifiers
Neurological or psychiatric conditions that compromise the reliable assessment of pain(dementia, cognitive impairment, severe communication disorders)
Chronic opioid use or regular use (> 3 months) of strong analgesics for chronic pain
History of allergy or known hypersensitivity to local anaesthetics
Coagulopathy or anticoagulant therapy precluding the safe performance of an intercostal block
Trial design
Treatments tested in this trial
- Intercostal nerve block before (ropivacaine 0.375%)
- Intercostal Nerve Bloc before (physiological serum)
- ICNB after (ropivacaine 0.375%)
- ICNB after (physiological serum)